Screener
Becton, Dickinson and Company BDX Medical — Research and development expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Becton, Dickinson and Company’s 10-K, filed November 25, 2025.
- Filed
- Nov 25, 2025
- Fiscal year
- FY2025
- Accession
- 0000010795-25-000099
| Fiscal Year 2025 / (Millions of dollars) | Medical | Life Sciences | Interventional | Total |
|---|---|---|---|---|
| % of revenues | 47.7% | 48.2% | 32.8% | |
| Selling and administrative expense | 1,312 | 721 | 997 | 3,030 |
| % of revenues | 11.5% | 14.0% | 19.1% | |
| Research and development expense | 523 | 315 | 255 | 1,092 |
| % of revenues | 4.6% | 6.1% | 4.9% | |
| Other operating expense, net | 17 | — | — | 17 |
| % of revenues | 0.2% | — | — | |
| Segment Operating Income | $4,140 | $1,641 | $2,253 | $8,034 |
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is Becton, Dickinson and Company's medical — research and development expense?
- Becton, Dickinson and Company (BDX) reported medical — research and development expense of $130.75M in Q3 2025.
- How has Becton, Dickinson and Company's medical — research and development expense changed year-over-year?
- Becton, Dickinson and Company's medical — research and development expense increased by 17.0% year-over-year, from $111.75M to $130.75M.
- What is the long-term trend for Becton, Dickinson and Company's medical — research and development expense?
- Over 2 years (2023 to 2025), Becton, Dickinson and Company's medical — research and development expense has grown at a 8.4% compound annual growth rate (CAGR), from $445M to $523M.
- What does medical — research and development expense mean?
- The total investment in research and development activities specifically allocated to the medical segment. This includes costs for new product innovation, clinical trials, and enhancing existing medical device technologies.
Ask your AI about Becton, Dickinson and Company's medical — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude